Showing 5881-5890 of 6035 results for "".
- Staying Fit Might Cut Glaucoma Riskhttps://modernod.com/news/staying-fit-might-cut-glaucoma-risk/2479921/Meeting physical activity guidelines and being physically fit may reduce the risk of developing glaucoma by 40 percent to 50 percent, recent research suggests, according to a Reuters
- CDC Launches the Nation’s First Vision and Eye Health Surveillance Systemhttps://modernod.com/news/cdc-launches-the-nations-first-vision-and-eye-health-surveillance-system/2479924/The Centers for Disease Control and Prevention (CDC) has developed the nation’s first Vision and Eye Health Surveillance System (VEHSS). Launched in collaboration with the National Opinion Research Center (NORC), the VEHSS is designed to help health care professionals, researchers, policymakers,
- Penn’s Experimental Gene Therapy Saves Night Vision in Dogs, Paving the Way for Human Testshttps://modernod.com/news/penns-experimental-gene-therapy-saves-night-vision-in-dogs-paving-the-way-for-human-tests/2479925/In 1990, scientists discovered a genetic mutation that turns an important light-sensing protein in the retina into a toxin that steadily destroys the ability to see in low light. <
- EyeGate Announces Enrollment of First Patient in PRK Pilot Studyhttps://modernod.com/news/eyegate-announces-enrollment-of-first-patient-in-prk-pilot-study/2479928/EyeGate Pharmaceuticals announced that the first patient has been enrolled in its pilot study evaluating the ability of EyeGate’s Ocular Bandage Gel (OBG) to accelerate re-epithelialization of large corneal epithelial defects in patients having undergone photorefractive keratectomy (PRK) surgery.
- University of Toledo Chemists Discover How Blue Light Speeds Blindnesshttps://modernod.com/news/university-of-toledo-chemists-discover-how-blue-light-speeds-blindness/2479929/Blue light from digital devices and the sun transforms vital molecules in the retina into cell killers, according to optical chemistry research at The University of Toledo. The process outlined in the study, which was recently published in the journal
- Roche’s Genentech Unit to Cut 223 Jobs in UShttps://modernod.com/news/roches-genentech-unit-to-cut-223-jobs-in-us/2479930/Roche’s Genentech unit plans to cut 223 jobs from its South San Francisco, California headquarters by the end of the year. The company, which disclosed the staff reductions in a Worker Adjustment and Retraining Notification (WARN) posted by the State of California’s Employment Develop
- Topcon Announces Date for 3rd Annual ISSOCT Conferencehttps://modernod.com/news/topcon-announces-date-for-3rd-annual-issoct-conference/2479931/Topcon Medical Systems has announced that the 3rd Annual ISSOCT Conference will be held on February 10-11, 2019 at the Sanibel Harbour Marriott Resort in Fort Myers, Florida. The world’s leading ophthalmologist
- FDA Approves 12-Week Dosing for Eylea in Wet AMD Patientshttps://modernod.com/news/fda-approves-12-week-dosing-for-eylea-in-wet-amd-patients/2479932/Regeneron announced that the FDA has approved a supplemental Biologics License Application for Eylea (aflibercept) injection in patients with wet age-related macular degeneration (AMD). The application was based on second-year data from the phase 3 VIEW 1 and 2 trials in which patients with wet A
- Mount Sinai Researchers Discover How to Restore Vision Using Retinal Stem Cellshttps://modernod.com/news/mount-sinai-researchers-discover-how-to-restore-vision-using-retinal-stem-cells/2479939/Researchers at Mount Sinai have successfully restored vision in mice through activating retinal stem cells, something that has never been done before. Their study, published in the August 15 online issue of Nature, could transform treatment for patients with retinal degenerative diseases
- Glasses May Boost Productivity for Rural Workershttps://modernod.com/news/glasses-may-boost-productivity-for-rural-workers/2479941/Providing reading glasses may be an inexpensive way to improve productivity, as well as earnings and quality of life, among workers in developing countries, suggests a clinical trial involving tea pickers in India, according to a Reuters Health